FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30007811000001102: Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    93675901000001110 Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    93676001000001118 Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Carbamazepine false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Carbamazepine false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP False Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier
    Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) 84 tablet Has AMP False Carbamazepine 200mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start